300149 睿智医药
已收盘 09-14 15:00:00
资讯
新帖
简况
睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%
证券之星 · 09-10
睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%
睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%
证券之星 · 09-07
睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%
睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%
证券之星 · 08-31
睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%
睿智医药（300149）2026年中报简析：增收不增利，应收账款上升
证券之星 · 08-30
睿智医药（300149）2026年中报简析：增收不增利，应收账款上升
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
证券之星 · 08-29
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
图解睿智医药中报：第二季度单季净利润同比下降168.50%
证券之星 · 08-29
图解睿智医药中报：第二季度单季净利润同比下降168.50%
8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股
证券之星 · 08-24
8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股
8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股
证券之星 · 08-21
8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股
8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股
证券之星 · 08-20
8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
证券之星 · 08-18
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
睿智医药：截止到2026年8月10日，公司的股东人数为45,400
证券之星 · 08-18
睿智医药：截止到2026年8月10日，公司的股东人数为45,400
8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股
证券之星 · 08-11
8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股
睿智医药：不涉及医药商业（流通/分销）业务
证券之星 · 08-11
睿智医药：不涉及医药商业（流通/分销）业务
睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司
证券之星 · 08-11
睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司
8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股
证券之星 · 08-07
8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股
睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%
证券之星 · 08-05
睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%
股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》
证券之星 · 08-05
股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%
证券之星 · 08-03
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%
睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%
证券之星 · 07-30
睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%
睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%
证券之星 · 07-27
睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%
暂无数据
公司概况
公司名称：
睿智医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2010-12-22
主营业务：
睿智医药科技股份有限公司的主营业务是提供生物药、化学药一站式医药研发及生产服务。公司的主要产品是化学业务、药效药动业务、大分子业务。
发行价格：
28.00
{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":9.02,"timestamp":1789369398000,"preClose":8.74,"halted":0,"volume":17328611,"delay":0,"changeRate":0.032,"floatShares":482000000,"shares":505000000,"eps":-0.0851,"marketStatus":"已收盘","change":0.28,"latestTime":"09-14 15:00:00","open":8.66,"high":9.08,"low":8.62,"amount":155000000,"amplitude":0.0526,"askPrice":9.02,"askSize":5,"bidPrice":9.01,"bidSize":258,"shortable":0,"etf":0,"ttmEps":-0.0851,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.74,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":9.61,"lowLimit":7.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":504985807,"isCdr":false,"pbRate":3.46,"roa":"--","roe":"--","epsLYR":0.03,"committee":-0.468537,"marketValue":4555000000,"turnoverRate":0.036,"status":0,"floatMarketCap":4344000000},"requestUrl":"/m/hq/s/300149/tweets","defaultTab":"tweets","newsList":[{"id":"2666561124","title":"睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561124","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561124?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:32","pubTimestamp":1789032728,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，睿智医药报收于8.97元，较前一交易日下跌3.24%，最新总市值为45.3亿元。睿智医药科技股份有限公司董事会于近日收到独立董事郭志成先生的书面辞职报告。郭志成先生自2020年9月10日起担任公司独立董事，连续任职即将届满六年，根据《上市公司独立董事管理办法》规定，申请辞去公司第六届董事会独立董事、审计委员会主任委员和薪酬与考核委员会委员职务。公司董事会对郭志成先生在任职期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000031588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314374","title":"睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314374?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:49","pubTimestamp":1788774555,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月31日公司股东户数为4.0万户，较8月10日减少5414.0户，减幅为11.93%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月31日，医疗服务行业平均股东户数为4.76万户。从股价来看，2026年8月10日至2026年8月31日，睿智医药区间跌幅为12.12%，在此期间股东户数减少5414.0户，减幅为11.93%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079783","title":"睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079783?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:43","pubTimestamp":1788169383,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，睿智医药报收于9.21元，较前一交易日下跌4.86%，最新总市值为46.51亿元。该股当日开盘9.3元，最高9.47元，最低9.1元，成交额达2.83亿元，换手率为6.34%。近日，睿智医药科技股份有限公司披露《2026年半年度报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663272048","title":"睿智医药（300149）2026年中报简析：增收不增利，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663272048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663272048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:27","pubTimestamp":1788042472,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期睿智医药发布2026年中报。本报告期睿智医药应收账款上升，应收账款同比增幅达36.09%。去年的净利率为1.19%，算上全部成本后，公司产品或服务的附加值不高。本文数据来源于睿智医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012964","title":"睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012964?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:16","pubTimestamp":1787995008,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月10日公司股东户数为4.54万户，较7月31日增加1572.0户，增幅为3.59%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.75万户。从股价来看，2026年7月31日至2026年8月10日，睿智医药区间涨幅为17.09%，在此期间股东户数增加1572.0户，增幅为3.59%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013332","title":"图解睿智医药中报：第二季度单季净利润同比下降168.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013332","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663013332?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:24","pubTimestamp":1787945090,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药2026年中报显示，上半年度公司主营收入5.62亿元，同比上升5.37%；归母净利润-3099.33万元，同比下降222.11%；扣非净利润-3194.82万元，同比下降570.36%；其中2026年第二季度，公司单季度主营收入2.96亿元，同比上升8.53%；单季度归母净利润-1283.68万元，同比下降168.5%；单季度扣非净利润-1219.8万元，同比下降245.85%；负债率34.32%，投资收益-176.56万元，财务费用1673.51万元，毛利率23.66%。财报数据概要请见下图:本文数据来源于睿智医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210172","title":"8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661210172?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:39","pubTimestamp":1787560787,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日睿智医药跌6.55%，收盘报9.7元，换手率7.03%，成交量33.86万手，成交额3.36亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244265","title":"8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661244265?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:45","pubTimestamp":1787301939,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日睿智医药跌8.55%，收盘报10.38元，换手率10.95%，成交量52.73万手，成交额5.58亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402067","title":"8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402067","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402067?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:42","pubTimestamp":1787215326,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日睿智医药涨10.41%，收盘报11.35元，换手率16.2%，成交量78.04万手，成交额8.73亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465255","title":"睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465255?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:29","pubTimestamp":1787045392,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月10日公司股东户数为4.54万户，较7月31日增加1572.0户，增幅为3.59%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.83万户。从股价来看，2026年7月31日至2026年8月10日，睿智医药区间涨幅为17.09%，在此期间股东户数增加1572.0户，增幅为3.59%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453626","title":"睿智医药：截止到2026年8月10日，公司的股东人数为45,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453626?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:51","pubTimestamp":1787014274,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至8月10日公司股东人数是多少？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年8月10日，公司的股东人数为45,400。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800007573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658864995","title":"8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658864995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658864995?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:38","pubTimestamp":1786437525,"startTime":"0","endTime":"0","summary":"证券之星消息，8月11日睿智医药涨5.63%创60日新高，收盘报11.07元，换手率17.1%，成交量82.33万手，成交额9.01亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100026182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969934","title":"睿智医药：不涉及医药商业（流通/分销）业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969934?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:36","pubTimestamp":1786419389,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在医药商业领域是否有布局？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。公司核心业务为医药研发及生产服务（CRO/CDMO），为国内外大中型制药企业、生物技术公司及科研院校提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务，不涉及医药商业（流通/分销）业务。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100014874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK1574","BK1161","159938","09939","BK1515","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969980","title":"睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969980?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:36","pubTimestamp":1786419380,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问今年2026年国内外CRO服务订单能不能大幅提升？今年新签多少家国内外客户？公司和国内外哪些大型药企进行合作？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。关于公司业务进展及经营情况，请关注公司定期报告；关于合作客户信息，公司长期服务于国内外大中型制药企业及生物技术公司，具体客户名单及合作细节涉及商业保密协议约定，不便披露，敬请谅解。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100014861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0216","BK1574","01477","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657169106","title":"8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657169106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657169106?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:47","pubTimestamp":1786092474,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日睿智医药涨7.53%，收盘报10.42元，换手率15.78%，成交量76.0万手，成交额7.68亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523552","title":"睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657523552?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:26","pubTimestamp":1785939978,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，睿智医药报收于9.7元，较前一交易日上涨1.89%，最新总市值为48.98亿元。公司于近日披露《关于控股股东、实际控制人及其一致行动人持股比例被动稀释触及1%整数倍的公告》。控股股东、实际控制人WOO SWEE LIAN先生及其一致行动人睿联投资、MEGA STAR、郑文略合计持股数量未变，合计持股比例由21.1811%被动稀释至20.8866%，被动稀释触及1%整数倍。本次权益变动不涉及股份减持，不触及要约收购，未导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657035565","title":"股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657035565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657035565?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:23","pubTimestamp":1785871421,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，睿智医药报收于9.52元，上涨4.5%，换手率9.65%，成交量45.78万手，成交额4.39亿元。当日关注点交易信息汇总：8月4日主力资金净流出39.03万元，游资资金净流入1396.51万元。公司公告汇总：8月5日完成2025年限制性股票激励计划首次授予部分第一个归属期登记，归属股份702.1815万股，总股本增至504,985,807股，控股股东及其一致行动人持股比例被动稀释至20.89%。股票来源为公司向激励对象定向发行A股普通股，不另设禁售期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500003829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377113","title":"睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377113","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377113?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:38","pubTimestamp":1785767899,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，睿智医药报收于9.11元，较前一交易日上涨1.79%，最新总市值为45.36亿元。该股当日开盘8.98元，最高9.13元，最低8.83元，成交额达1.78亿元，换手率为4.16%。公告显示，公司于2026年8月5日完成2025年限制性股票激励计划首次授予部分第一个归属期的股份归属登记，本次归属日为2026年8月5日，归属股票数量为702.1815万股，归属对象共计107人。本次归属后公司总股本增至504,985,807股，控股股东及其一致行动人持股比例被动稀释至20.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655784805","title":"睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655784805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655784805?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:23","pubTimestamp":1785421395,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，睿智医药报收于8.6元，较前一交易日下跌3.8%，最新总市值为42.82亿元。公告显示，公司于2026年5月18日聘任吴文华先生为董事会秘书，因其当时尚未取得深圳证券交易所董事会秘书培训证明，暂由董事长代行职责。截至公告披露日，吴文华先生已通过培训并取得《上市公司董事会秘书培训证明》，自取得证明之日起正式履行董事会秘书职责。公司董事会确认董事长代行职责时间未超过九个月，符合相关监管要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016610","title":"睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654016610?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:36","pubTimestamp":1785144967,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年7月10日公司股东户数为3.98万户，较6月30日减少2034.0户，减幅为4.86%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.91万户。从股价来看，2026年6月30日至2026年7月10日，睿智医药区间跌幅为6.18%，在此期间股东户数减少2034.0户，减幅为4.86%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789400146450,"stockEarnings":[{"period":"1week","weight":-0.0213},{"period":"1month","weight":-0.1907},{"period":"3month","weight":0.1091},{"period":"6month","weight":-0.1381},{"period":"1year","weight":-0.3251},{"period":"ytd","weight":-0.0858}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"39986人(较上一季度减少11.93%)","perCapita":"12043股","listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","registeredCapital":"50498万元","survey":" 睿智医药科技股份有限公司的主营业务是提供生物药、化学药一站式医药研发及生产服务。公司的主要产品是化学业务、药效药动业务、大分子业务。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}